Cargando…
Therapeutic Potential of Targeting the Ghrelin Pathway
Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora of physiological effects that go far beyond its initial characterization as a growth hormone (GH) secretagogue. Among the numerous w...
Autores principales: | Colldén, Gustav, Tschöp, Matthias H., Müller, Timo D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412382/ https://www.ncbi.nlm.nih.gov/pubmed/28398233 http://dx.doi.org/10.3390/ijms18040798 |
Ejemplares similares
-
Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
por: Müller, Timo D., et al.
Publicado: (2010) -
Ghrelin regulation of glucose metabolism
por: Poher, Anne-Laure, et al.
Publicado: (2018) -
Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice
por: Jall, Sigrid, et al.
Publicado: (2019) -
Corrigendum to “Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice” [Molecular Metabolism 23 (2019) 75–81]
por: Jall, Sigrid, et al.
Publicado: (2019) -
Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin
por: Collden, Gustav, et al.
Publicado: (2014)